Management of Acute Urticaria in Pregnancy
For acute urticaria in pregnancy, start with chlorphenamine (chlorpheniramine) as first-line therapy due to its long safety record, or alternatively use loratadine or cetirizine (FDA Pregnancy Category B drugs), and add a short 3-day course of oral prednisolone (at reduced doses) only if symptoms are severe or intolerable. 1
First-Line Treatment: Antihistamines
Preferred Agents in Pregnancy
While guidelines emphasize that it is best to avoid all antihistamines in pregnancy, especially during the first trimester, none has been shown to be teratogenic in humans 1. When treatment is necessary:
Chlorphenamine (chlorpheniramine) is most commonly chosen by U.K. clinicians when antihistamine therapy is necessary because of its long safety record 1
Loratadine and cetirizine are classified as FDA Pregnancy Category B drugs, meaning no evidence of harm to the fetus exists, though well-controlled human studies are unavailable 1
Second-generation H1 antihistamines should be used in pregnant individuals due to their safety profile 2
Critical Contraindication
Hydroxyzine is specifically contraindicated during early pregnancy per U.K. manufacturer guidelines and should be avoided 1
Dosing Strategy
- Start with standard doses of the chosen second-generation antihistamine
- Adjust timing of medication to ensure highest drug levels when urticaria is most active 1
- For cetirizine: offers shortest time to maximum concentration, advantageous when rapid relief is needed 1
Second-Line: Short-Course Corticosteroids
For severe acute urticaria that is intolerable or unresponsive to antihistamines:
- Oral prednisolone 50 mg daily for 3 days in adults may shorten duration 1
- Lower doses are often effective and should be considered in pregnancy to minimize fetal exposure 1
- Parenteral hydrocortisone is reserved for severe laryngeal edema or anaphylaxis, though its action is delayed 1
Important Caveats and Pitfalls
What NOT to Do
- Do not use long-term corticosteroids for urticaria management in pregnancy 1
- Avoid hydroxyzine entirely in pregnancy 1
- Avoid first-generation sedating antihistamines as monotherapy when possible due to concerns about reduced concentration and performance, though chlorphenamine remains acceptable when needed 1
Additional Considerations
H2 antihistamines (ranitidine, cimetidine) may provide better control when added to H1 antihistamines, though this is off-license and may be more helpful for accompanying dyspepsia 1
Antileukotrienes have little evidence as monotherapy but may be added to antihistamines for poorly controlled cases 1
Emergency Management
For anaphylaxis or severe laryngeal angioedema:
- Intramuscular epinephrine 0.5 mL of 1:1000 (500 µg) can be life-saving 1
- Use with caution in hypertension and ischemic heart disease 1
Clinical Reasoning
The evidence base specifically for acute urticaria in pregnancy is limited 3, 4. The 2007 British guidelines provide the most direct pregnancy-specific recommendations 1, emphasizing avoidance when possible but recognizing that treatment is often necessary for maternal comfort and safety. The choice of chlorphenamine reflects decades of clinical use without documented teratogenicity, while loratadine and cetirizine have formal FDA Category B designation. Recent research confirms that second-generation antihistamines should be preferred in pregnant patients 2, 3, though the older guidelines' recommendation of chlorphenamine remains valid given its safety track record.
The recommendation for short-course corticosteroids (3 days) for severe acute urticaria is evidence-based 1, though clinicians should use lower doses than the standard 50 mg in pregnancy when possible to minimize fetal exposure while maintaining maternal symptom control.